What is it about?
In Bangladesh, the estimated prevalence of diabetes among adults was 9.7% in 2011 and the number is projected to be 13.7 million by 2045. The cost of diabetes care is considerably high in Bangladesh, and it is primarily driven by the medicine and hospitalization costs. According to Bangladesh Bureau of Statistics, in 2017 the annual average cost per T2DM was $864.7, which is 52% of per capita GDP of Bangladesh and 9.8 times higher than the general health care cost. Medicine is the highest source of direct cost (around 85%) for patients without hospitalization. The private and public financing of diabetes treatment will be severely constrained in near future, representing a health threat for the Bangladeshi population.
Featured Image
Photo by Kate on Unsplash
Read the Original
This page is a summary of: TRACK Implementation: a Bangladesh Scenario, Central Asian Journal of Global Health, May 2020, University Library System, University of Pittsburgh,
DOI: 10.5195/cajgh.2020.416.
You can read the full text:
Contributors
The following have contributed to this page
